Version 2023 of the Classic pKa calculator in Percepta® includes a significantly expanded training set for improved prediction accuracy, broader chemical applicability, and algorithmic changes that deliver impressive speed enhancements to this industry-leading software. San Francisco, US —26 years after the release of their first ionization predictor, ACD/Labs, an informatics company that develops and commercializes software in support […]

Cambridge, UK – Torx ® Software Limited, announces the release of Torx 2.0, extending the platform’s scientific reach and capabilities to deliver unrivalled seamless integration across the drug discovery Design-Make-Test-Analyze (DMTA) cycle. Torx is a visual, chemistry aware, cloud-native platform. By enabling chemistry teams to design molecules, track compound synthesis from start to finish and […]

We are excited to announce our partnership with EDB, the leading provider of Postgres-based data management solutions. Our collaboration brings together EDB Postgres Advanced Server and Chemaxon’s JChem PostgreSQL Cartridge to offer customers a comprehensive and seamless solution for chemical structure searching and management. The certificate opens up new possibilities for our users by integrating our […]

Appointment will lead research strategy to apply the latest scientific innovations to Optibrium’s computational and AI drug discovery technologies Hamed brings extensive computational engineering and design experience from industry leader, Illumina CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the appointment of Dr Hamed Tabatabaei Ghomi as […]

The collaboration will connect PostEra’s synthesis prediction technology with Optibrium’s comprehensive platform for design, optimisation and data analysis for small molecule discovery CAMBRIDGE, UK and BOSTON, USA – Optibrium, a leading developer of software and AI for small molecule discovery, and PostEra, an AI-first biotechnology company with advanced machine learning (ML) technology for preclinical discovery, today […]

New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses PRINCETON, NJ — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, is adding deep learning capabilities to D360, a leading scientific informatics software platform. The addition of novel A.I. will enable discovery scientists to integrate multiple structured […]

Cambridge, UK – Torx® Software Limited, provider of the ground-breaking Torx technology platform for managing small molecule discovery chemistry, today ­announced a collaboration with CAS, a division of the American Chemical Society, to connect CAS SciFindern users seamlessly through the Torx platform to streamline workflows for discovery chemistry. The integration expands on the intrinsic design and analysis capabilities within […]

New and updated fragment databases from ChEMBL and SureChEMBL are now available in Spark. This new release of databases significantly expands the available chemistry to Spark users by including the latest compounds from scientific literature, as well as previously unseen compounds from chemical patents. Combined with databases of fragments derived from screening compounds, and with custom databases which […]

New role will lead global commercial strategy and development as Optibrium continues to scale its drug discovery technologies and team Latest in a series of senior hires as the Company continues its rapid growth trajectory Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the appointment of […]

-Accelerating the development of small molecule drugs using materials informatics technology- Tokyo – Hitachi High-Tech Solutions Corporation (“Hitachi High-Tech Solutions”), in collaboration with Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences is commencing joint research that uses Materials Informatics (MI) (hereinafter, “the Research”) to improve the efficiency of the development of small molecule drugs*1. Hitachi […]